Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$274.90 USD

274.90
1,518,178

+3.90 (1.44%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $275.00 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (231 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: Microsoft, Oracle, Medtronic, Booking and Cigna

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Microsoft, Oracle, Medtronic, Booking and Cigna

Sheraz Mian headshot

Top Research Reports for Microsoft, Oracle & Medtronic

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Oracle (ORCL) and Medtronic (MDT).

Zacks Equity Research

Cigna Banks on Diversified Business, Solid Capital Position

by Zacks Equity Research

Cigna's (CI) prolific business profile creates a steady revenue recovery trajectory while its solid financial footing enables reinvestment in business

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 31st

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 31st

Zacks Equity Research

Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y

by Zacks Equity Research

Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.

Zacks Equity Research

Cigna (CI) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 15.05% and 4.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Cigna (CI) Keep the Beat Streak Alive in Q2 Earnings?

by Zacks Equity Research

Cigna's (CI) business is likely to have been weighed down in Q2 due to high unemployment rate, partly offset by the delay in elective procedures resulting in lower claims.

Zacks Equity Research

Why Cigna (CI) Might Surprise This Earnings Season

by Zacks Equity Research

Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus

by Zacks Equity Research

Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.

Zacks Equity Research

Strong Bond Issuance Volume to Aid Moody's (MCO) Q2 Earnings

by Zacks Equity Research

Moody's (MCO) is expected to have benefited from growth in bond issuance volumes in second-quarter 2020.

Zacks Equity Research

Zacks.com featured highlights include: Quest Diagnostics, eBay, Cisco Systems, Cigna and AbbVie

by Zacks Equity Research

Zacks.com featured highlights include: Quest Diagnostics, eBay, Cisco Systems, Cigna and AbbVie

Urmimala Biswas headshot

5 Coronavirus-Proof GARP Stocks to Pick on Discounted PEG

by Urmimala Biswas

A lower PEG ratio, preferably less than 1, is always better for GARP investors.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 24th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 24th

Zacks Equity Research

Cigna (CI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 22nd

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 22nd.

Zacks Equity Research

Level Up Your Portfolio With These High Earnings Yield Picks

by Zacks Equity Research

The earnings potential of a stock is an important consideration while making investment decisions. This makes the Earnings Yield ratio a handy tool for stock selection.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 21st

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 21st.

Zacks Equity Research

Old Republic (ORI) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Old Republic's (ORI) Q2 results are likely to reflect solid performance of its Title Insurance and General Insurance segments.

Zacks Equity Research

eHealth (EHTH) Gears Up for Q2 Earnings: What's in Store?

by Zacks Equity Research

eHealth's (EHTH) Q2 results are likely to reflect solid performance at Medicare and individual and family plan business.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for July 20th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 20th

Zacks Equity Research

Is Cigna (CI) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

UnitedHealth's Therapy to Guide People With Type 2 Diabetes

by Zacks Equity Research

UnitedHealth (UNH) rolls out a digital health therapy - Level2, which will result in improved health outcomes for people with type 2 diabetes.

Zacks Equity Research

UnitedHealth (UNH) to Post Q2 Earnings: Will Revenue Rise Aid?

by Zacks Equity Research

Solid segmental revenues are likely to have aided UnitedHealth's (UNH) earnings performance in Q2.

Tanuka De headshot

6 Insurers Poised to Outperform Q2 Earnings Estimates

by Tanuka De

Better pricing and underwriting practice, product repositioning and sturdy capital will help these insurers outperform Q2 earnings estimates.

Sapna Bagaria headshot

6 Health Insurance Stocks Poised to Beat on Earnings in Q2

by Sapna Bagaria

Health insurers' second-quarter 2020 earnings results are likely to gain from lower healthcare utilization, partly offset by higher costs.